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Abstract
Background: The US11 protein of herpes simplex virus type 1 (HSV-1) is a small, highly basic phosphoprotein
expressed at late times during infection. To date, the function of US11 protein in cell culture and animal models is
poorly understood. To further investigate the function of the US11 protein, this study was undertaken to express
the US11 protein and raise a polyclonal antibody.
Results: The US11 gene was cloned into the prokaryotic expression vector pET-32a (+) to express His-tagged US11
protein in Escherichia coli. After purification by nickel affinity chromatography and refolding, the recombinant
protein was used to raise the anti-US11 polyclonal antibody. Western blot analysis demonstrated that the US11
protein was specifically recognized by the polyclonal antibody, and immunofluorescent assay also showed that the
antibody was able to probe the US11 protein in the cells infected with HSV-1.
Conclusions: In the present study, we obtained a high-level expression of the recombinant US11 protein as well
as high titers of rabbit polyclonal antibody specially against US11 protein in HSV-1 infected cells. This special
polyclonal antibody provides a good tool for further studying structural and functional characterization of HSV-1
US11 protein.
Keywords: Herpes simplex virus type 1 (HSV-1), US11 protein, Protein expression, Polyclonal antibody, Immuno-
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Background
Herpes simplex virus type 1 (HSV-1) is a large DNA virus
that latently infects neurons and periodically reinitiates
productive growth at epithelial sites, causing blisters, or
in the central nervous system, resulting in encephalitis.
During productive infection, the 152-kb double-stranded
HSV-1 genome is rapidly translocated to the nucleus
where at least 80 viral genes are transcribed by the host
cell RNA polymerase II (Pol II) [1]. Expression of the
viral genes occurs in a coordinately activated cascade
fashion that consists of the sequential expression of
immediate-early (IE), early (E), and late (L) genes [2].
The US11 protein expresses at late times during HSV-1
infection and is one of the late genes of HSV-1 [3].
The US11 protein is a 21 kDa, highly basic phosphopro-
tein [4], and is also an RNA-binding protein, post-tran-
scriptional regulator of gene expression [5-7]. US11 is
present in the nucleus, particularly concentrated in the
nucleolus, and the cytoplasm [8,9] and is present in the vir-
ion as a component of the tegument (approximately 600 to
1,000 molecules per virion). Furthermore, US11 interacts
with several different cellular proteins such as human ubi-
quitous kinesin heavy chain (uKHC) [10], homeodomain
interacting protein kinase 2 (HIPK2) [11], double-stranded
RNA-dependent protein kinase (PKR) and a dsRNA-inde-
pendent protein activator of PKR (PACT) [12,13]. US11
has been reported as a potent inhibitor of PKR activation
through binding to dsRNA [14] or through direct interac-
tion with PKR in the context of viral infection [12] and
therefore could interfere with the PKR mediated host cell
responses. Finally, US11 has been recently shown to also
counteract the activity of the 2’-5’ oligoadenylate synthetase
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Therefore, it is clear that US11 is a multifunctional protein
involved in HSV-1 infection.
In the present study, the US11 gene was cloned into
pET-32a(+) to yield pET-32a-US11. The His-tagged
US11 protein was then expressed in E. coli BL21 (DE3)
cells and purified by a nickel-nitrilotriacetic acid (Ni
2
+-NTA) affinity resin under denaturing conditions. Sub-
sequently, a polyclonal antibody was raised against the
purified His-tagged US11 prote i ni nr a b b i t s .F i n a l l y ,t h e
reactivity and specificity of the polyclonal antibody were
characterized by Western blot and immunofluorescent
assays.
Results
Construction of the US11 prokaryotic expression plasmid
The full-length US11 gene, which is composed of 459 bp
(base pairs) and predicted to encode a protein of 152
amino acids, was amplified successfully from the HSV-1
(strain F) genome (Figure 1, lane 1). The PCR product was
digested with EcoRI and SalI and inserted into pET-32a
(+) digested with the same enzymes to yield the recombi-
nant expression plasmid pET-32a-US11. Then, the recom-
binant plasmid was verified by colony PCR (Figure 1, lane
2) and restriction enzymes digestion (Figure 1, lane 3).
T h es e q u e n c i n gr e s u l ta l s os h o w e dt h a tt h e r ew a sn o
mutation of amino acid sequences (data not shown).
Expression of the His-tagged US11 protein
After induction with 1.0 mM IPTG at 37°C for 4h,
E. coli BL21 (DE3) harboring pET-32a-US11 exhibited a
high level of expression (Figure 2A, lane 3). A distinct
band of approximately 40 kDa, corresponding to the
expected molecular weight of the His-tagged US11 pro-
tein, was found only after induction (Figure 2A, lanes 2-
7), whereas there was no expression of the US11 protein
in BL21(DE3) harboring pET32a-US11 without IPTG
induction (Figure 2A, lane 1).
Additionally, according to the SDS-PAGE analysis of the
soluble fraction and cell debris pellet (Figure 2A, lanes 8
and 9), the majority of the induced protein was found in
the cell debris pellets (Figure 2A, lane 9), suggesting that
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Figure 1 Construction of the recombinant plasmid pET-32a-
US11. Lane 1, the PCR product of the US11 gene; Lane 2, the
recombinant plasmid pET-32a-US11 was confirmed by PCR; Lane 3,
the recombinant plasmid pET-32a-US11 digested with EcoRI and
SalI; and Lane M, the DNA marker. Arrowhead indicates the position
of the US11 fragment.
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Figure 2 Expression analysis and optimization of the
expression for the His-tagged US11 protein. (A) Analysis of
expressed His-tagged US11 protein and optimization of the IPTG
concentration and induction temperature. Lane 1, total protein from
BL21 (DE3) with pET32a-US11 before induction; Lanes 2-5, total
protein from pET32a-US11 transformed BL21 (DE3) after induction
with the concentrations of IPTG: 0.5, 1, 1.5 and 2 mM, respectively.
Lanes 6 and 7, total protein from pET-32a-US11 transformed BL21
(DE3) after induction at 30°C and 37°C, respectively. Lane 8, soluble
fractions; Lane 9, insoluble fractions; Lane 10, the purified US11
protein after dialysis; Lane M, the protein maker. (B) Optimization of
the induction duration. Lanes 1-7, total protein from pET32a-US11
transformed BL21 (DE3) after induction with IPTG (1 mM) for 0, 1, 2,
3, 4, 5 and 6 h, respectively, at 37°C. Lane M, the protein maker.
Arrowheads indicate the position of the His-tagged US11 protein.
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inclusion bodies. Meanwhile, several expression para-
meters, including IPTG concentrations (Figure 2A, lanes
2-5), induction temperatures (Figure 2A, lanes 6 and 7)
and induction times (Figure 2B), were tested to optimize
the expression of the US11 protein as previously described
[16]. As results, the recombinant protein was found to
have the highest expression under the following condition,
namely 1 mM IPTG (Figure 2A, lane 3) for 5 h (Figure 2B,
lane 6) at 37°C (Figure 2A, lane 7).
Purification of the His-tagged US11 protein
The His-tagged US11 protein was purified as previously
described [16]. The SDS-PAGE results verified the suc-
cessful purification, because only one clear band with
molecular weight about 40 kDa was observed (Figure 2A,
lane 10). After purification, the His-tagged US11 protein
was quantified. The result showed that the concentration
of the purified His-tagged US11 protein was 911.3 μg/ml
(data not shown).
Production and characterization of the polyclonal
antibody against purified His-tagged US11 protein
After three immunizations, the rabbit antiserum was col-
lected as previously described [16]. Western blot results
demonstrated that the anti-US11 polyclonal antibody
reacted with one band with apparent molecular masses of
21 kDa in Vero cells infected with HSV-1 (Figure 3, lane
5) at a dilution of 1:800. In contrast, no band was detected
in mock infected Vero cells (Figure 3, lane 4). Moreover,
the anti-US11 polyclonal antibody could recognize the
band with apparent molecular weight of 40 kDa in lysate
of E. coli BL21 (DE3) transformed with the plasmid pET-
32a-US11 after induction by IPTG (Figure 3, lane 3) and
the expected 23 kDa band in lysate of HEK293T cells
transfected with plasmid encoding US11-HA protein
(Figure 3, lane 1), whereas no band was detected in lysate
of E. coli BL21 (DE3) (Figure 3, lane 2).
Immunofluorescent assay revealed that anti-US11 poly-
clonal antibody identified the US11 protein expressed in
the cells infected with HSV-1. The results demonstrated
that the US11 protein localized in the cytoplasm and
nucleolus of the infected cell (Figure 4C), which is consis-
tent with previous reports [9,17]. In contrast, there was
no staining in mock infected cells (Figure 4B) or HSV-1
infected cells detected with the preimmune serum (Fig-
ure 4A). These results suggested that the polyclonal anti-
body had good reactivity and specificity against the US11
protein in infected cells, which were consistent with pre-
vious studies involved [10-12,18].
Discussion
In general, recombinant proteins are the most common
source of the diagnostic reagents and can be expressed
in mammalian, insect and bacterial cells [19-21]. While
each of these systems has its advantages [22], the bacter-
ial expression system is one of the most universally used
and has been employed widely due to multiple factors,
including its relative inexpensive cost, ease of manipula-
tion and rapid growth rate [23]. However, different
codon usage pattern in E. coli can cause diminished the
production of heterologous eukaryotic protein. Many E.
coli strains, such as BL21 CodonPlus and Rosetta-2
derived from BL21, are optimized to enhance expression
of gene sequences that contain codons used rarely by E.
coli [24]. Because there are a few rare codons in the
US11 gene, three different E. coli strains, including E.
coli BL21 (DE3), BL21 CodonPlus and BL21 Rosetta
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Figure 3 Western blot analysis of US11 with anti-US11 polyclonal antibody. Lane 1, the lysate of HEK293T cells transfected with plasmid
encoding full-length US11-HA protein; Lane 2, total protein from E. coli BL21 (DE3); Lane 3, total protein from E. coli BL21 (DE3) harboring the
plasmid pET-32a-US11 after induction by IPTG; Lane 4, the lysate of mock infected Vero cells; Lane 5, the lysate of Vero cells infected with HSV-1;
Lane M, the protein maker (kDa). Arrowheads indicate the position of the US11 protein.
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tein. As a result, the His-tagged US11 protein could be
expressed in all of these three bacteria hosts, but with a
slight better expression in E. coli BL21 (DE3) (data not
shown). Additionally, different expression parameters
were tested to optimize the expression of the US11 pro-
tein, demonstrating that the US11 protein gained the
highest expression under the condition of 37°C (Figure
2A, lane 7) with 1 mM IPTG (Figure 2A, lane 3) for 5 h
(Figure 2B, lane 6).
It is very common that high level expression of
recombinant proteins in E. coli result in the formation
of insoluble and inactive aggregate known as inclusion
bodies [25]. Although the proteins in the inclusion
bodies are easy to purify and are protected from the
intracellular protease, they are synthesized in the form
of misfolding or partial folding polypeptides. Therefore,
purified inclusion bodies must undergo the process of
protein renaturation. In the present study, denaturation
solution was removed by dilution or dialysis, which per-
mitted renaturation of the His-tagged US11 proteins.
However, the proteins purified from the inclusion bodies
are not suitable for the researches that require the cor-
rect protein conformation.
The US11 protein is among the most-abundant viral
proteins present in cells late in infection and is packaged
in the tegument of the native virions [17]. In this study,
anti-US11 polyclonal antibody reacted with one band
with apparent molecular masses of 21 kDa in Vero cells
infected with HSV-1 for 24 h., which is consistent with
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Figure 4 Indirect immunofluorescent assay of the US11 protein in Vero cells infected with HSV-1. (A) HSV-1 infected Vero cells probed
with the preimmune serum. (B) Mock infected and (C) HSV-1 infected Vero cells probed with the US11 antiserum. Cells were labeled with FITC-
conjugated goat anti-rabbit immunoglobulin G (A-C) and counterstained with Hoechst to visualize the nuclei (D-F). Magnification, 40×.
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bodies against US11 [4,10-12]. The specificity of our
US11 polyclonal antibody was confirmed by both WB
and IFA in transfected and infected cells, and it also
worked well, which maybe special advantages of our
antibody over those antibodies. The subcellular localiza-
tion of a viral protein determines its function. It is
reported that soon after HSV-1 infection, the US11 pro-
tein is found in the cytoplasm, either as heterogeneous
oligomers or associated with ribosomes or both [26,27].
Later during infection, the US11 protein accumulates
into nucleoli and is also found in RNP fibrils as well as
in clusters of interchromatin granules. As expected, our
results also demonstrate that the US11 protein localizes
in the cytoplasm and nucleolus of the infected cell.
Early studies have demonstrated US11 is a multifunc-
tional protein involved in posttranscriptional regulation
of gene expression and in biological processes related to
the survival of cells following environmental stress [11].
To further gain insight into the molecular mechanisms
underlying the multiple functions of this protein, identi-
fication of cellular factors capable of interacting with the
US11 protein is necessary. Therefore, the anti-US11
polyclonal antibody may serve as a useful tool for
further study of US11 interaction partners by co-
immunoprecipitation.
Conclusions
In the present study, we obtained a high-level expression
of the recombinant US11 protein as well as high titers
of rabbit polyclonal antibody against US11 protein spe-
cially. The anti-US11 serum was able to detect the US11
protein in HSV-1 infected cells and the US11 protein
localized in the cytoplasm and nucleolus of the infected
cell. This special polyclonal antibody provides a good
tool for further studying structural and functional char-
acterization of HSV-1 US11 protein.
Materials and methods
Construction of the plasmid expressing the His-tagged
US11 protein
The US11 gene of HSV-1 (strain F) was amplified by PCR
using KOD plus polymerase (Toyobo, Osaka, Japan) from
the pYEbac102 [28] using the following primers: 5’
CGGAATTCATGAGCCAGACCCAACC 3’ and 5’
ACGCGTCGACTACAGACCCGCGAGCCGT 3’ as pre-
viously described. The purified PCR product was digested
with EcoRI and SalI (Takara, Dalian, China), and inserted
into pET-32a (+) (Novagen, Shanghai, China) to generate
a recombinant plasmid pET-32a-US11.
Expression of the His-tagged US11 protein
E.coli BL21 (DE3) was transformed with pET-32a-US11
and the transformant was inoculated into LB medium
containing 50 μg/ml ampicillin and grown for 12 h at
37°C. The culture was transferred to fresh LB medium
and grown at 37°C until the OD600 reached about 0.5.
Then the recombinant protein was induced by isopro-
pyl-b-D-thiogalactopyranoside (IPTG) at a final concen-
tration of 1 mM for 4 h. The total bacterial lysates were
analyzed by SDS-PAGE [29].
To increase the yield, the expression of the His-tagged
US11 protein was optimized as previously described [16]
at different temperatures (30°C and 37°C), different con-
centrations of IPTG (0.5, 1.0, 1.5 and 2.0 mM), and
varying durations of induction (0, 1, 2, 3, 4, 5 and 6 h).
Protein expression was assessed by SDS-PAGE.
Analysis of the solubility of the His-tagged US11 protein
The analysis was performed as previously described [16].
Purification and renaturation of the His-tagged US11
protein
The purification and renaturation of the His-tagged
US11 protein were performed as previously described
[16]. After analysis by 12% SDS-PAGE, the yield of the
purified His-tagged US11 protein was quantified by
Coomassie (Bradford) Protein Assay Kit (Pierce, Beijing,
China) [30].
Production of polyclonal antibody against the His-tagged
US11 protein
The immunizations were performed as previously
described [16], except that the His-tagged US11 fusion
protein was used in this study.
Western blot
Western blot was performed as previously described
[16], except that the anti-US11 polyclonal antibody
(1:800 dilution) was applied in this study.
Indirect immunofluorescent assay
Immunofluorescent assay was performed as previously
described [16]. However, the Vero cells were infected
with the HSV-1 at a MOI of 1 and fixed 20 h after
infection. Additionally, the anti-US11 polyclonal anti-
body at a dilution of 1:800 was applied in this study.
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